# Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease

> **NCT06635902** · PHASE2 · RECRUITING · sponsor: **Suvankar Majumdar** · enrollment: 99 (estimated)

## Conditions studied

- Sickle Cell Disease
- Vaso-occlusive Pain Episode

## Interventions

- **DRUG:** L-citrulline
- **OTHER:** Placebo
- **DRUG:** L-citrulline

## Key facts

- **NCT ID:** NCT06635902
- **Lead sponsor:** Suvankar Majumdar
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-22
- **Primary completion:** 2028-06
- **Final completion:** 2029-03
- **Target enrollment:** 99 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06635902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06635902, "Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06635902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*